TY - JOUR
T1 - Temporal airway microbiome changes related to ventilator-associated pneumonia in children
AU - Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN)
AU - Mourani, Peter M.
AU - Sontag, Marci K.
AU - Williamson, Kayla M.
AU - Harris, J. Kirk
AU - Reeder, Ron
AU - Locandro, Chris
AU - Carpenter, Todd C.
AU - Maddux, Aline B.
AU - Ziegler, Katherine
AU - Simões, Eric A.F.
AU - Osborne, Christina M.
AU - Ambroggio, Lilliam
AU - Leroue, Matthew K.
AU - Robertson, Charles E.
AU - Langelier, Charles
AU - DeRisi, Joseph L.
AU - Kamm, Jack
AU - Hall, Mark W.
AU - Zuppa, Athena F.
AU - Carcillo, Joseph
AU - Meert, Kathleen
AU - Sapru, Anil
AU - Pollack, Murray M.
AU - McQuillen, Patrick
AU - Notterman, Daniel A.
AU - Dean, J. Michael
AU - Wagner, Brandie D.
N1 - Funding Information:
Conflict of interest: P.M. Mourani reports grants from NIH NHLBI and NIH NICHD, during the conduct of the study. M.K. Sontag reports grants from NIH NHLBI, during the conduct of the study. K.M. Williamson has nothing to disclose. J.K. Harris has nothing to disclose. R. Reeder has nothing to disclose. C. Locandro has nothing to disclose. T.C. Carpenter reports grants from NIH NHLBI and NIH NICHD, during the conduct of the study. A.B. Maddux reports a grant from Parker B. Francis Foundation (Fellowship Award) and NIH/NICHD K23HD096018, outside the submitted work. K. Ziegler reports grants from NIH NHLBI during the conduct of the study. E.A.F. Simões reports grants from NIH NHLBI, during the conduct of the study. C.M. Osborne has nothing to disclose. L. Ambroggio has nothing to disclose. M.K. Leroue has nothing to disclose. C.E. Robertson has nothing to disclose. C. Langelier has nothing to disclose. J.L. DeRisi reports grants from NIH NHLBI, during the conduct of the study. J. Kamm has nothing to disclose. M.W. Hall reports grants from NIH NICHD, during the conduct of the study. A.F. Zuppa has nothing to disclose. J. Carcillo has nothing to disclose. K. Meert reports grants from NIH, during the conduct of the study. A. Sapru reports grants from NIH NICHD, during the conduct of the study. M.M. Pollack reports grants from NIH, during the conduct of the study. P. McQuillen reports grants from NIH NICHD, during the conduct of the study. D.A. Notterman has nothing to disclose. J.M. Dean reports grants from NIH, during the conduct of the study. B.D. Wagner reports grants from NIH NHLBI, during the conduct of the study.
Funding Information:
Support Statement: Supported in part, by the following cooperative agreements from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and Heart Lung Blood Institute (NHLBI), National Institutes of Health (NIH): UG1HD083171 (P.M. Mourani), 1R01HL124103 (P.M. Mourani and M.K. Sontag) UG1HD049983 (J. Carcillo), UG01HD049934 (R. Reeder, C. Locandro and J.M. Dean), UG1HD083170 (M.W. Hall), UG1HD050096 (K. Meert), UG1HD63108 (A.F. Zuppa), UG1HD083116 (A. Sapru), UG1HD083166 (P. McQuillen), UG1HD049981 (M.M. Pollack), and K23HL138461-01A1 (C. Langelier). The study sponsors were not involved in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication. Funding information for this article has been deposited with the Crossref Funder Registry.
Publisher Copyright:
Copyright ©ERS 2021
PY - 2021/3/1
Y1 - 2021/3/1
N2 - We sought to determine whether temporal changes in the lower airway microbiome are associated with ventilator-associated pneumonia (VAP) in children. Using a multicentre prospective study of children aged 31 days to 18 years requiring mechanical ventilation support for >72 h, daily tracheal aspirates were collected and analysed by sequencing of the 16S rRNA gene. VAP was assessed using 2008 Centers for Disease Control and Prevention paediatric criteria. The association between microbial factors and VAP was evaluated using joint longitudinal time-to-event modelling, matched case–control comparisons and unsupervised clustering. Out of 366 eligible subjects, 66 (15%) developed VAP at a median of 5 (interquartile range 3–5) days post intubation. At intubation, there was no difference in total bacterial load (TBL), but Shannon diversity and the relative abundance of Streptococcus, Lactobacillales and Prevotella were lower for VAP subjects versus non-VAP subjects. However, higher TBL on each sequential day was associated with a lower hazard (hazard ratio 0.39, 95% CI 0.23–0.64) for developing VAP, but sequential values of diversity were not associated with VAP. Similar findings were observed from the matched analysis and unsupervised clustering. The most common dominant VAP pathogens included Prevotella species (19%), Pseudomonas aeruginosa (14%) and Streptococcus mitis/pneumoniae (10%). Mycoplasma and Ureaplasma were also identified as dominant organisms in several subjects. In mechanically ventilated children, changes over time in microbial factors were marginally associated with VAP risk, although these changes were not suitable for predicting VAP in individual patients. These findings suggest that focusing exclusively on pathogen burden may not adequately inform VAP diagnosis.
AB - We sought to determine whether temporal changes in the lower airway microbiome are associated with ventilator-associated pneumonia (VAP) in children. Using a multicentre prospective study of children aged 31 days to 18 years requiring mechanical ventilation support for >72 h, daily tracheal aspirates were collected and analysed by sequencing of the 16S rRNA gene. VAP was assessed using 2008 Centers for Disease Control and Prevention paediatric criteria. The association between microbial factors and VAP was evaluated using joint longitudinal time-to-event modelling, matched case–control comparisons and unsupervised clustering. Out of 366 eligible subjects, 66 (15%) developed VAP at a median of 5 (interquartile range 3–5) days post intubation. At intubation, there was no difference in total bacterial load (TBL), but Shannon diversity and the relative abundance of Streptococcus, Lactobacillales and Prevotella were lower for VAP subjects versus non-VAP subjects. However, higher TBL on each sequential day was associated with a lower hazard (hazard ratio 0.39, 95% CI 0.23–0.64) for developing VAP, but sequential values of diversity were not associated with VAP. Similar findings were observed from the matched analysis and unsupervised clustering. The most common dominant VAP pathogens included Prevotella species (19%), Pseudomonas aeruginosa (14%) and Streptococcus mitis/pneumoniae (10%). Mycoplasma and Ureaplasma were also identified as dominant organisms in several subjects. In mechanically ventilated children, changes over time in microbial factors were marginally associated with VAP risk, although these changes were not suitable for predicting VAP in individual patients. These findings suggest that focusing exclusively on pathogen burden may not adequately inform VAP diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=85103226548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103226548&partnerID=8YFLogxK
U2 - 10.1183/13993003.01829-2020
DO - 10.1183/13993003.01829-2020
M3 - Article
C2 - 33008935
AN - SCOPUS:85103226548
SN - 0903-1936
VL - 57
JO - Scandinavian Journal of Respiratory Diseases
JF - Scandinavian Journal of Respiratory Diseases
IS - 3
M1 - 2001829
ER -